Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Nosocomial infections due to multidrug-resistant bacteria in cancer patients: a six-year retrospective study of an oncology Center in Western China

Fig. 2

Antimicrobial susceptibility patterns of nosocomial infections caused by MDR bacteria in cancer patients. a The isolated MDRGNB. b The isolated MRSA. TGC Tigecycline, LVX Levofloxacin, CIP Ciprofloxacin, CRO Ceftriaxone, CAZ Ceftazidime, FEP Cefepime, MEM Meropenem, IMP Imipenem, ATM Aztreonam, TZP Piperacillin/tazobactam, GEN Gentamicin, AMK Amikacin, PEN Penicillin, CLI Clindamycin, MFX Moxifloxacin, TEC Teicoplanin, VAN Vancomycin, LNZ Linezolid, MNO Minocycline, TCY Tetracycline.

Back to article page